New Square Capital LLC Eli Lilly & CO Transaction History

New Square Capital LLC

$1.23 Billion
Q3 2024

A detailed history of New Square Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, New Square Capital LLC holds 5,248 shares of LLY stock, worth $4.13 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

5,248

Previous 4,784 9.7%

Holding current value

$4.13 Million

Previous $4.33 Million 7.34%

% of portfolio

0.38%

Previous 0.38%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$772.14 - $960.02 $358,272 - $445,449	464 Added 9.7%	5,248 $4.65 Million
Q2 2024 Jul 23, 2024	BUY	$724.87 - $909.04 $310,244 - $389,069	428 Added 9.83%	4,784 $4.33 Million
Q1 2024 May 08, 2024	BUY	$592.2 - $792.28 $101,858 - $136,272	172 Added 4.11%	4,356 $3.39 Million
Q4 2023 Feb 01, 2024	BUY	$525.19 - $619.13 $101,886 - $120,111	194 Added 4.86%	4,184 $2.44 Million
Q3 2023 Nov 03, 2023	BUY	$434.7 - $599.3 $1.63 Million - $2.25 Million	3,749 Added 1555.6%	3,990 $2.14 Million
Q2 2023 Aug 03, 2023	BUY	$350.74 - $468.98 $36,476 - $48,773	104 Added 75.91%	241 $113,000
Q1 2023 May 01, 2023	SELL	$310.63 - $364.82 $407,546 - $478,643	-1,312 Reduced 90.55%	137 $47,000
Q4 2022 Feb 06, 2023	BUY	$321.55 - $374.67 $461,102 - $537,276	1,434 Added 9560.0%	1,449 $530,000
Q3 2022 Oct 25, 2022	BUY	$296.48 - $337.87 $4,447 - $5,068	15 New	15 $5,000
Q2 2022 Jul 26, 2022	BUY	$278.73 - $327.27 $0 - $0	0 New	0 $0
Q1 2022 May 10, 2022	SELL	$234.69 - $291.66 $26,050 - $32,374	-111 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$180.55 - $233.54 $11,555 - $14,946	64 Added 136.17%	111 $25,000
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $2,464 - $3,190	-15 Reduced 24.19%	47 $9,000
Q4 2020 Feb 04, 2021	SELL	$130.46 - $172.63 $652 - $863	-5 Reduced 7.46%	62 $10,000
Q3 2020 Nov 04, 2020	SELL	$146.22 - $169.13 $5,556 - $6,426	-38 Reduced 36.19%	67 $10,000
Q1 2020 May 08, 2020	SELL	$119.05 - $147.35 $4,166 - $5,157	-35 Reduced 25.0%	105 $15,000
Q2 2019 Aug 20, 2019	SELL	$110.79 - $129.32 $229,889 - $268,339	-2,075 Reduced 93.68%	140 $16,000
Q1 2019 Apr 25, 2019	BUY	$111.31 - $131.02 $12,800 - $15,067	115 Added 5.48%	2,215 $287,000
Q4 2018 Jan 22, 2019	BUY	$105.9 - $118.64 $222,390 - $249,144	2,100 New	2,100 $243,000
Q1 2018 Apr 24, 2018	SELL	$74.21 - $87.6 $2,448 - $2,890	-33 Closed	0 $0
Q4 2017 Jan 29, 2018	BUY	$81.94 - $87.89 $2,704 - $2,900	33	33 $3,000

Others Institutions Holding LLY

# of Institutions

3,994

Shares Held

752M

Call Options Held

7.31M

Put Options Held

9.23M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $747B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Square Capital LLC with notifications on news.

Account

New Square Capital LLC Eli Lilly & CO Transaction History